tiprankstipranks
Trending News
More News >
Dexcom (DXCM)
NASDAQ:DXCM
US Market

Dexcom (DXCM) Ratios

Compare
4,393 Followers

Dexcom Ratios

DXCM's free cash flow for Q4 2025 was $0.63. For the 2025 fiscal year, DXCM's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.88 1.88 1.47 2.84 1.99
Quick Ratio
1.59 1.59 1.28 2.48 1.83
Cash Ratio
0.43 0.43 0.21 0.36 0.35
Solvency Ratio
0.30 0.30 0.18 0.17 0.15
Operating Cash Flow Ratio
0.67 0.67 0.34 0.48 0.36
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.82 0.00 0.87
Net Current Asset Value
$ 439.40M$ 439.40M$ -80.50M$ 230.00M$ 408.90M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.22 0.40 0.41 0.40
Debt-to-Equity Ratio
0.51 0.51 1.23 1.25 1.01
Debt-to-Capital Ratio
0.34 0.34 0.55 0.56 0.50
Long-Term Debt-to-Capital Ratio
0.31 0.31 0.37 0.54 0.36
Financial Leverage Ratio
2.31 2.31 3.08 3.03 2.53
Debt Service Coverage Ratio
76.91 0.00 0.66 36.84 0.65
Interest Coverage Ratio
64.67 0.00 31.58 29.44 21.03
Debt to Market Cap
0.05 0.05 0.08 0.05 0.04
Interest Debt Per Share
3.63 3.56 6.44 6.77 5.56
Net Debt to EBITDA
0.35 0.41 2.10 2.21 2.66
Profitability Margins
Gross Profit Margin
60.10%60.10%60.46%63.19%64.72%
EBIT Margin
23.27%19.56%18.05%20.17%14.07%
EBITDA Margin
28.67%24.96%23.45%25.31%19.43%
Operating Profit Margin
19.56%19.56%14.88%16.50%13.44%
Pretax Profit Margin
23.35%23.35%17.58%19.61%13.43%
Net Profit Margin
17.94%17.94%14.29%14.95%11.73%
Continuous Operations Profit Margin
17.94%17.94%14.29%14.95%11.73%
Net Income Per EBT
76.84%76.84%81.27%76.22%87.31%
EBT Per EBIT
119.37%119.37%118.17%118.86%99.90%
Return on Assets (ROA)
13.19%13.19%8.89%8.64%6.33%
Return on Equity (ROE)
32.44%30.46%27.40%26.18%16.01%
Return on Capital Employed (ROCE)
21.72%21.72%16.89%12.69%11.01%
Return on Invested Capital (ROIC)
16.61%16.61%10.20%9.63%7.86%
Return on Tangible Assets
13.39%13.39%9.06%8.87%6.57%
Earnings Yield
3.21%3.23%1.83%1.13%0.77%
Efficiency Ratios
Receivables Turnover
3.61 3.61 3.90 3.67 3.87
Payables Turnover
5.40 5.40 4.62 4.82 4.32
Inventory Turnover
2.96 2.96 2.94 2.38 3.35
Fixed Asset Turnover
2.85 2.85 2.88 3.06 2.56
Asset Turnover
0.74 0.74 0.62 0.58 0.54
Working Capital Turnover Ratio
2.47 2.86 1.90 1.54 1.21
Cash Conversion Cycle
156.87 156.87 138.70 177.03 118.81
Days of Sales Outstanding
100.99 100.99 93.54 99.51 94.35
Days of Inventory Outstanding
123.45 123.45 124.18 153.18 109.03
Days of Payables Outstanding
67.56 67.56 79.03 75.66 84.58
Operating Cycle
224.44 224.44 217.73 252.69 203.39
Cash Flow Ratios
Operating Cash Flow Per Share
3.73 3.69 2.45 1.94 1.72
Free Cash Flow Per Share
2.79 2.76 1.56 1.33 0.78
CapEx Per Share
0.94 0.93 0.89 0.61 0.94
Free Cash Flow to Operating Cash Flow
0.75 0.75 0.64 0.68 0.46
Dividend Paid and CapEx Coverage Ratio
3.96 3.96 2.76 3.16 1.84
Capital Expenditure Coverage Ratio
3.96 3.96 2.76 3.16 1.84
Operating Cash Flow Coverage Ratio
1.04 1.04 0.38 0.29 0.31
Operating Cash Flow to Sales Ratio
0.31 0.31 0.25 0.21 0.23
Free Cash Flow Yield
4.10%4.16%2.00%1.07%0.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
31.11 30.97 54.61 88.46 129.24
Price-to-Sales (P/S) Ratio
5.63 5.56 7.80 13.22 15.15
Price-to-Book (P/B) Ratio
9.47 9.43 14.97 23.16 20.68
Price-to-Free Cash Flow (P/FCF) Ratio
24.36 24.04 49.89 93.57 144.72
Price-to-Operating Cash Flow Ratio
18.06 17.98 31.80 63.99 65.86
Price-to-Earnings Growth (PEG) Ratio
1.92 0.66 39.32 1.39 2.26
Price-to-Fair Value
9.47 9.43 14.97 23.16 20.68
Enterprise Value Multiple
19.98 22.66 35.37 54.46 80.66
Enterprise Value
26.75B 26.37B 33.45B 49.93B 45.60B
EV to EBITDA
20.01 22.66 35.37 54.46 80.66
EV to Sales
5.74 5.66 8.29 13.78 15.67
EV to Free Cash Flow
24.83 24.48 53.03 97.53 149.65
EV to Operating Cash Flow
18.57 18.30 33.80 66.70 68.11
Tangible Book Value Per Share
6.86 6.79 4.88 4.95 4.96
Shareholders’ Equity Per Share
7.10 7.04 5.20 5.36 5.47
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.19 0.24 0.13
Revenue Per Share
12.06 11.95 9.97 9.38 7.47
Net Income Per Share
2.16 2.14 1.42 1.40 0.88
Tax Burden
0.77 0.77 0.81 0.76 0.87
Interest Burden
1.00 1.19 0.97 0.97 0.95
Research & Development to Revenue
0.13 0.13 0.14 0.14 0.17
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.03 0.04 0.04 0.04
Income Quality
1.72 1.72 1.72 1.38 1.96
Currency in USD